Goodrx Holdings Ownership
| GDRX Stock | USD 4.92 0.17 3.58% |
Shares in Circulation | First Issued 2019-03-31 | Previous Quarter 383.6 M | Current Value 379.7 M | Avarage Shares Outstanding 396 M | Quarterly Volatility 22.6 M |
Goodrx Stock Ownership Analysis
About 12.0% of the company shares are held by company insiders. The book value of Goodrx Holdings was currently reported as 1.81. The company has Price/Earnings To Growth (PEG) ratio of 1.98. Goodrx Holdings had not issued any dividends in recent years. GoodRx Holdings, Inc., through its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company was incorporated in 2015 and is headquartered in Santa Monica, California. GoodRx Holdings operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 756 people. To learn more about Goodrx Holdings call the company at 855 268 2822 or check out https://www.goodrx.com.Goodrx Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Goodrx Holdings is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Goodrx Holdings backward and forwards among themselves. Goodrx Holdings' institutional investor refers to the entity that pools money to purchase Goodrx Holdings' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Technology Crossover Management X, Ltd. | 2025-03-31 | 1.7 M | Connor Clark & Lunn Inv Mgmt Ltd | 2025-03-31 | 1.4 M | Evr Research Lp | 2025-03-31 | 1.3 M | Geode Capital Management, Llc | 2025-03-31 | 1.1 M | Clearbridge Advisors, Llc | 2025-03-31 | 1 M | Millennium Management Llc | 2025-03-31 | 912.3 K | Jacobs Levy Equity Management, Inc. | 2025-03-31 | 816.7 K | Goldman Sachs Group Inc | 2025-03-31 | 783.4 K | Citadel Advisors Llc | 2025-03-31 | 748.3 K | Francisco Partners Management Lp | 2025-03-31 | 60.1 M | Vanguard Group Inc | 2025-03-31 | 8.6 M |
Goodrx Holdings Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Goodrx Holdings insiders, such as employees or executives, is commonly permitted as long as it does not rely on Goodrx Holdings' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Goodrx Holdings insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Goodrx Holdings Outstanding Bonds
Goodrx Holdings issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Goodrx Holdings uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Goodrx bonds can be classified according to their maturity, which is the date when Goodrx Holdings has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Goodrx Stock Analysis
When running Goodrx Holdings' price analysis, check to measure Goodrx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Goodrx Holdings is operating at the current time. Most of Goodrx Holdings' value examination focuses on studying past and present price action to predict the probability of Goodrx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Goodrx Holdings' price. Additionally, you may evaluate how the addition of Goodrx Holdings to your portfolios can decrease your overall portfolio volatility.